IP Library Granted Patent US 8,586,053
Granted Patent B2
US 8,586,053 · App. 12/067,735 · Granted Nov 19, 2013

Composition and use of phyto-percolate for treatment of disease

Inventor: Tiffany Thomas (Phoenix, AZ)
Assignee: Health Enhancement Products, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,586,053
App. No.
12/067,735
Granted
Nov 19, 2013
Kind
B2
Abstract

This invention relates generally to a method of preparation of a phyto-percolate that is derived from fresh water mixture including algae. The invention further relates to the use of the phyto-percolate in a variety of disease states. The phyto-percolate is believed to contain an activity that induces the reduction of soluble and insoluble fibrin. Further, the phyto-percolate is believed to reduce oxidative stress in the body.

Claims (14)

1. A method of treating inflammation or managing weight in a mammal, said method comprising administering to said mammal a therapeutically effective amount of phyto-percolate derived from culturing microorganisms of ATCC Deposit #PTA-5863.

2. The method of claim 1 , wherein said phyto-percolate has fibrinolytic activity.

3. The method of claim 1 , wherein said therapeutically effective amount is between about 1 ounce to about 20 ounces per day of said phyto-percolate.

4. The method of claim 1 , wherein said inflammation is an inflammatory disorder selected from the group comprised of arthritis, rheumatoid arthritis, ulcerative colitis, and inflammatory bowel disease.

5. The method of claim 1 , wherein said mammal is selected from the group consisting of a human, a dog, a cat, a horse, and a cow.

6. The method of claim 1 , wherein said compound functions as a broad spectrum anti-inflammatory agent.

7. The method of claim 1 wherein said inflammation is acute inflammation.

8. The method of claim 1 wherein said inflammation is chronic inflammation.

9. The method of claim 7 wherein said acute inflammation is generalized.

10. The method of claim 7 wherein said acute inflammation is specifically located.

11. The method of claim 8 wherein said chronic inflammation is generalized.

12. The method of claim 8 wherein said chronic inflammation is specifically located.

13. The method of claim 1 wherein said mammal is a pig.

14. The method of claim 1 wherein said mammal is a hog.

Assignments (4)
CORRECTIVE ASSIGNMENT TO CORRECT THE SCHEDULE A IN ITS ENTIRETY PREVIOUSLY RECORDED ON REEL 027531 FRAME 0882. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY AGREEMENT. Recorded Mar 5, 2012
From: HEALTH ENHANCEMENT PRODUCTS, INC.
To: HEP INVESTMENTS LLC
Reel/Frame 027808/0553 →
SECURITY AGREEMENT Recorded Jan 13, 2012
From: HEALTH ENHANCEMENT PRODUCTS, INC.
To: HEP INVESTMENTS LLC
Reel/Frame 027531/0882 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 24, 2010
From: THOMAS, TIFFANY
To: HEALTH ENHANCEMENT PRODUCTS, INC.
Reel/Frame 024132/0549 →
NOTICE OF ATTORNEY'S LIEN Recorded Jan 12, 2009
From: HEALTH ENHANCEMENT PRODUCTS, INC.
To: BROWN RUDNICK LLP
Reel/Frame 022091/0560 →
Continuity (3)
Provisional Application 60719025 · Sep 21, 2005
Provisional Application 60741774 · Dec 2, 2005
Related Publication 20090036372A1 · Feb 5, 2009